Janssen Vaccines & Prevention BV

Janssen Vaccines & Prevention BV is a company in Leiden, Netherlands that has taken part in 20 EU-funded projects since 2012, receiving €1.8M in EU funding.

EU funding received€1.8M
EU projects20
As coordinator0
Running now6
First EU project2012
Latest project2026
CountryNetherlands
EU registration (PIC)963020463
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Janssen Vaccines & Prevention BV's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€654k · 4 projects
  • Horizon 2020€581k · 10 projects
  • Horizon Europe€531k · 5 projects
  • Erasmus+ (ERASMUS+)€0 · 1 project

Projects

20 EU-funded projects, newest first. Each links to the official record.

  • FORTIFYAssociated partner

    FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

  • VICT3RAssociated partner

    Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • LIVE_InnovAssociated partner

    Leading International Vaccinology Education for Innovation

    Erasmus+ (ERASMUS+) · 2024–2030 · Project on the EU portal ↗

  • iAdsPartner

    Intelligent design of adenovirus vectors (iAds)

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €531ktheir share
  • IDERHAPartner

    Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • ReCHISVacAssociated partner

    Experimental vaccinology, revealing unnatural signatures of protection by repeat controlled human schistosome infection.

    Horizon Europe · 2022–2024 · Project on CORDIS ↗

  • PrIMAVeRaPartner

    Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

  • INITIATEPartner

    INnate-ImmunomeTabolIsm as Antiviral TargEt

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €266ktheir share
  • VITALPartner

    Vaccines and Infectious Diseases in the Ageing PopuLation

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

  • EBOVAC3Partner

    Bringing a prophylactic Ebola vaccine to licensure

    Horizon 2020 · 2018–2024 · Project on CORDIS ↗

  • OptiMalVaxPartner

    Optimizing a deployable high efficacy malaria vaccine

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €25ktheir share
  • EDGEPartner

    Training network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €255ktheir share
  • EHVAPartner

    European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

    Horizon 2020 · 2016–2023 · Project on CORDIS ↗

    €35ktheir share
  • FLUCOPPartner

    Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection

    FP7 (2007 to 2013) · 2015–2020 · Project on CORDIS ↗

  • EBOMANPartner

    Manufacturing and Development for Rapid Access Ebola Vaccine (EBOMAN) – Sofia ref.: 115850

    Horizon 2020 · 2014–2017 · Project on CORDIS ↗

  • EBOVAC1Partner

    Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854

    Horizon 2020 · 2014–2021 · Project on CORDIS ↗

  • EBOVAC2Partner

    Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861

    Horizon 2020 · 2014–2021 · Project on CORDIS ↗

  • ADVANCEPartner

    Accelerated Development of Vaccine benefit-risk Collaboration in Europe

    FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗

  • AD-VECPartner

    Adenovirus Vector Technology: Next Generation Systems for Medical Therapy

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €336ktheir share
  • ADVANCEPartner

    ADenoViruses as novel clinical treatments

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €318ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • HIV
  • antibiotic resistance
  • artificial intelligence
  • bacteriology
  • cardiovascular diseases
  • data processing
  • databases
  • differential equations
  • ebola
  • epidemiology
  • genomes
  • governance
  • immunisation
  • immunology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime